FOSTER CITY, Calif.--(BUSINESS WIRE)--Oxis International Inc. (OTCBB:OXIS), a biopharmaceutical company focused on commercializing predictive biomarkers, clinical assays and nutraceutical and therapeutic products, announced today that CEO, Marvin S. Hausman MD., will present a poster entitled: “A Novel Method To Assess In-Vivo The Antioxidant Potential of Dietary Supplements and Foods” at the Supply Side West meeting in Las Vegas, Nevada, November 6-8, 2007.
